Clinical trials to evaluate the vaccine’s safety and effectiveness as a booster are being conducted at Cuba’s La Pradera International Health Center and the Amedeo di Savoia Hospital, in the Italian city of Turin
november 22, 2021@ 09:11:48 | Liz Conde Sánchez
The help of only five Cuban health care professionals was no small thing for the British island of Anguilla, where they contributed to the battle against COVID-19
march 26, 2021@ 08:03:52 | Liz Conde Sánchez
The aim is to have a formulated vaccine candidate ready to be evaluated in animal models in 2023.
february 23, 2023@ 08:02:03 | Liz Conde Sánchez
Cuba broke the figure of 1 million visitors received in 2023, thus surpassing the number of visitors who arrived in our country on the same date in 2022, informed Juan Carlos García Granda, Minister of Tourism.
may 12, 2023@ 08:05:41 | Liz Conde Sánchez
Army General Raúl Castro Ruz and President Miguel Díaz-Canel Bermúdez honored José Martí yesterday with some twenty young people who descended the steps of the University of Havana in the traditional March of the Torches.
january 28, 2021@ 09:01:40 | Leticia Martínez Hernández y Liz Conde Sánchez
More than four million doses of the anti-COVID-19 vaccine Abdala were delivered to the Mexican Health Secretariat, after the arrival of a first batch to that country on Friday. The vaccine will be used in the ongoing immunization of the adult population, informed the BioCubaFarma Business Group.
december 8, 2022@ 07:12:25 | Liz Conde Sánchez
It is Friday, family visit day in the José Martí Integral Formation School (EFI in Spanish), attached to the Ministry of the Interior (MININT).
april 7, 2022@ 10:04:33 | Liz Conde Sánchez
The fire fighters who worked to extinguish the fire in the Fuel Storage Base in Matanzas, including those who died in the line of duty, will be honored for their heroism
september 7, 2022@ 13:09:52 | Liz Conde Sánchez
This Saturday, delegates to the 8th Party Congress analyzed, in their commissions, the Central Report presented by Army General Raúl Castro on opening day
april 18, 2021@ 15:04:23 | Yaima Puig Meneses; Leticia Martínez Hernández; Walkiria Juanes Sánchez; Liz Conde Sánchez y Yudy Castro Morales
The vaccine candidate Mambisa - developed by the Center for Genetic Engineering and Biotechnology (CIGB) - is currently in the final stages of clinical trials and, based on the results obtained in the analyses, will apply to the Center for State Control of Medicines, Equipment and Medical Devices for authorization for emergency use as a booster dose in the next few weeks.
april 7, 2022@ 10:04:33 | Liz Conde Sánchez